Did you see our workshops and poster presentations at this year’s ISPOR conference in Washington, DC?

Click below to learn more about our workshops and download our posters from the conference.

Workshops:

• Systematic Approaches to Assessing Physician Decision-Making Practices and Treatment Preferences (#106)
  • Participants: Katherine Batt, Marlon Graf, Suepattra May-Slater
  • When: Monday, May 16 at 10:15-11:15 AM

• Measuring Health Equity: Lessons from an Integrated Healthcare System (#142)
  • Participants: Alice Pressman, Kristen Azar, Stephen H. Lockhart
  • When: Monday, May 16 at 4:30-5:30 PM

Posters:

• The Cost-Effectiveness of Atidarsagene Autotemcel for the Treatment of Metachromatic Leukodystrophy (MLD) in France
  • Authors: Francis Pang, Rebecca Dean,  Ivar Jensen, Andrew Olaye, Beck Miller
  • When: Session begins on Monday, May 16 at 9:45 AM

• Budget Impact (BI) of First-Line (1L) Cemiplimab Monotherapy for Advanced Non-Small Cell Lung Cancer (aNSCLC) with Programmed Cell Death-Ligand 1 (PD-L1) ≥50% in a Large US Health Plan: An Updated Analysis
  • Authors: Ruben Quek, Chloi Theriou, Caitlin Smare, Sam Keeping, Yingxin Xu, Gerasimos Konidaris, Patrick LaFontaine, James Harnett
  • When: Session begins on Tuesday, May 17 at 9:45 AM

• Number Needed to Treat Analysis of Nivolumab Versus Surveillance for the Adjuvant Treatment of Patients with Resected Esophageal Cancer (EC) or Gastroesophageal Junction Cancer (GEJC)
  • Authors: Prianka Singh, Sarah Kassahun, Kabirraaj Toor, Inkyu Kim, Sumie Kakehi, Elvira Estella-Pérez, Meena Venkatachalam
  • When: Session begins on Tuesday, May 17 at at 9:45 AM

• Efficacy Outcomes Following Treatment with Bruton Tyrosine Kinase Inhibitors (BTKi) for Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL): A Literature-Based Meta Analysis
  • Authors: Martin Dreyling, B Shah, JJ Wu, Jenny MH Chen, Sam Keeping, Keith Chan, Sally Wade, Weimin Peng, Iona Kloos, M Wang
  • When: Session begins on Tuesday, May 17 at at 9:45 AM

• Initial Treatment Patterns for Newly-Diagnosed Commercially Insured Patients with Psoriasis
  • Authors: Laura Panattoni, Jennifer Hernandez, Yanmei Liu, Naomi C. Sacks, Robert Higham, Brett Stephenson, April Armstrong
  • When: Session begins on Tuesday, May 17, 2022 at 3 PM

• Cost Implications of Adverse Event Profiles in Second Generation Androgen Receptor Inhibitor (SGARI) Treatments for Non-Metastatic Castration Resistant Prostate Cancer (NMCRPC)
  • Authors: Jacki Chou, Eric Bell, Iris Brewer, Sree Appukkuttan, Jamie Partridge, Sheldon Kong, Ross Maclean
  • When: Session begins on Wednesday, May 18, 2022 at 9 AM

• Economic Impact of Sequential Testing for COVID-19 and Influenza with Molecular Point of Care in 3 European Countries
  • Authors: Jason Shafrin, Anuj Mubayi, Kelly Birch, Natalie Land, Michelle Sotak, Meena Venkatachalam, Chloi Theriou, Michael Ayad
  • When: Session begins on Wednesday, May 18 at 9 AM